Register for OBR daily


GH_edutorial_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ONCY $1.07 0.3415 +46.88%
OHRP $9.78 2.0900 +27.18%
APRI $2.53 0.3300 +15.00%
PTLA $40.76 2.6800 +7.04%
CLDX $27.13 1.5900 +6.23%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CALA $13.76 -1.4600 -9.59%
BPTH $1.70 -0.1500 -8.11%
AVEO $1.17 -0.0800 -6.40%
GTXI $0.75 -0.0500 -6.25%
PVCT $0.88 -0.0410 -4.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Coffee Intake May Lower Endometrial Cancer Risk

(AACR) Feb 6, 2015 - Women who drank about four cups of coffee per day appeared to have decreased endometrial cancer risk compared with those who drank less than a cup each day, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
read press release 



New Tool Helps Identify Lung Cancer Patients Who Will Respond to Immune Therapies

(Yale Cancer Center) Feb 4, 2015 - A Yale-led team of researchers has developed a new assay, or investigative tool, to measure the anti-tumor immune activity in non-small cell lung cancer tumors that could lead to a more accurate determination of which patients will respond to immune therapy drugs. Findings from the study were published in the Journal of the National Cancer Institute.
read press release 



Taking Immunosuppressives, Anti-Cancer Drugs May Reactivate Hepatitis B

(Wiley) Feb 5, 2015 - Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease.
read press release 



Patient Voices Essential, as Docs Underreport Toxicities

(Medscape Medical News) Feb 5, 2015 - The voices of cancer patients are essential when it comes to reporting toxic effects in clinical trials because physicians tend to under-report.
read article (free registration required) 



Ten-year Post-Treatment Analysis of German ARO 96-02 Indicates Patients With Detectable PSA After Radical Prostatectomy Should Receive More Aggressive Radiation Therapy Treatment

(ASTRO) Feb 5, 2015 - Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
read press release 



Medicare Will Cover CT Lung Cancer Screening

(MedPage Today/The Gupta Guide) Feb 5, 2015 - Current and former heavy smokers ages 55 to 77 can undergo annual low-dose CT screening for lung cancer paid by Medicare, the Centers for Medicare and Medicaid Services announced Thursday.
read article (free registration required) 



National Coverage Determination (NCD) For Screening For Lung Cancer With Low Dose Computed Tomography (LDCT)

(CMS.gov) Feb 5, 2015 - Today the Centers for Medicare & Medicaid Services (CMS) issued a final national coverage determination that provides for Medicare coverage of Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). The coverage is effective immediately.
read press release 



GSK Announces Positive Overall Survival Results from Phase III COMBI-d Study of Dabrafenib (Tafinlar™) and Trametinib (Mekinist™) Combination

(GSK) Feb 6, 2015 - GlaxoSmithKline plc today announced overall survival (OS) results from COMBI-d which demonstrate a statistically significant reduction in the risk of death (Hazard Ratio [HR] 0.71 [95% Confidence Interval (CI): 0.55, 0.92], p=0.011) for the combination of dabrafenib (Tafinlar™) and trametinib (Mekinist™) compared to dabrafenib monotherapy in patients with BRAF V600E/K mutation-positive metastatic melanoma.
read corporate press release 



Exclusive: Apple's Health Tech Takes Early Lead Among Top Hospitals

(Reuters) Feb 5, 2015 - Apple Inc's healthcare technology is spreading quickly among major U.S. hospitals, showing early promise as a way for doctors to monitor patients remotely and lower costs.
read article 



FDA Head to Step Down, Chief Scientist Taking Over

(ABC News/Associated Press) Feb 5, 2015 - From food safety to tobacco and politically charged drug approvals, Margaret Hamburg reset the course of the embattled Food and Drug Administration, an agency that had often been seen as ineffective.
read article 



There’s a Smartphone Attachment That Will Test For HIV in 15 Minutes

(TIME) Feb 4, 2015 - A team of researchers from Columbia University has developed a device that can be plugged into a smartphone and used to quickly test for HIV and syphilis. The device tests for three infectious-disease markers in just 15 minutes by using a finger-prick of blood.
read article 



Massive Breach at Health Care Company Anthem Inc.

(USA Today) Feb 5, 2015 - As many as 80 million customers of the nation's second-largest health insurance company, Anthem Inc., have had their account information stolen, the company said in a statement.
read article 



Navigating Cancer Now Offers Single Sign-On Functionality For Its Patient Engagement Portal

(Yahoo! Finance) Feb 5, 2015 - Navigating Cancer offers patients added flexibility and ease as they manage their cancer diagnosis across more than one cancer clinic.
read article 



8 Strategies to Help Gastric Cancer Patients Cope With Nutrition Problems During Treatment

(ACCCBuzz) Feb 2, 2015 - More than 70 percent of patients with gastric cancer develop malnutrition, depleting muscle mass, slowing healing, and limiting the immune system.
read article 



Drugmaker Valeant Raises Bid For Dendreon Cancer Vaccine

(Reuters) Feb 5, 2015 - Valeant Pharmaceuticals International Inc said on Thursday it has raised its bid for worldwide rights to a prostate cancer vaccine owned by bankrupt drugmaker Dendreon Corp.
read article 



Cancer Genetics, Inc. Selected to Power Molecular and Biomarker Testing For Six Clinical Trials With Leading Biotech Companies Focused on Hematological Cancers

(MarketWatch) Feb 5, 2015 - Cancer Genetics, Inc., an emerging leader in DNA-based cancer diagnostics, announced today that it has signed on and begun testing for clinical trials with leading biotech companies working on blood-borne cancers.
read article 



ASH Comments on NIH Single IRB Policy

(ASH) Feb 4, 2015 - On January 28, The American Society of Hematology (ASH) submitted comments on the National Institutes of Health’s (NIH) Draft Policy to promote the use of a single Institutional Review Board (IRB) of record for domestic sites of multi-site clinical studies funded by NIH.
read article 



Following NICE's Exclusive Recommendation, NHS England Agrees to Access Program For Oncotype DX(R) Breast Cancer Test

(Genomic Health) Feb 5, 2015 - Genomic Health, Inc. announced today that, as of April 1, 2015, the Oncotype DX® test will be available to eligible breast cancer patients through the National Health Service (NHS) in England as the only multi-gene breast cancer test recommended by the National Institute for Health and Care Excellence (NICE) for use as an option to assist in chemotherapy treatment decision-making.
read corporate press release 



URMC Announces New Breast Diagnostic Device

(Rochester Democrat and Chronicle) Feb 4, 2015 - A new imaging system developed at the University of Rochester Medical Center that uses 3-D technology that gives a more precise view of breast tissue without compressing the breast has been cleared for marketing by the Food and Drug Administration, the university announced Wednesday.
read article 



In Speed Mode, FDA Approves Pfizer’s Big New Drug Early

(Fortune) Feb 4, 2015 - The U.S. Food and Drug Administration isn’t exactly known for acting fast, but that may be changing.
read article 



Helsinn and Zealand Announce the Advance of Elsiglutide Into Phase IIB Development For the Prevention of Chemotherapy-Induced Diarrhea

(Yahoo! Finance) Feb 5, 2015 - Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID).
read article 



New Biomarkers to Spot Pancreatic Cancer Early

(University College London [UK]) Feb 5, 2015 - Pancreatic cancer could be diagnosed up to two years earlier by screening for two tumour markers found in blood, according to research published in Clinical Cancer Research.
read press release 



New Device Could Be Solution For the Most Deadly Form of Cancer

(FoxNews.com) Feb 4, 2015 - A team of researchers at the University of North Carolina at Chapel Hill found by using electric fields, they were able to eliminate problems with dense surrounding tissue and drive chemotherapy drugs directly into pancreatic cancer tumors, preventing growth and in some cases shrinking them.
read article 



Two Major Studies Strengthen Case For Prostate Cancer Drug Before Chemotherapy

(Institute of Cancer Research [UK]) Feb 5, 2015 - Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
read press release 



Study Finds Genetic Mutation Behind Most Common Breast Cancer

(The Telegraph [UK]) Feb 5, 2015 - Scientists have hailed a significant breakthrough after a major study identified two genetic variations linked to the most common form of breast cancer, which strikes 70 per cent of those with the disease.
read article